Keros Therapeutics, Inc. Balance Sheet

Balance Sheet Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Assets
Assets 10.96M269.44M255.25M306.78M370.02M615.89M
Current Assets
Cash & Equivalents 7.02M265.88M230.04M279.05M331.15M559.93M
Cash & Current Investments 7.02M265.88M230.04M279.05M331.15M559.93M
Receivables - Net 18.00M0.14M2.74M
Receivables - Other 0.92M
Receivables 18.00M0.14M2.74M
Prepaid Assets 0.38M1.85M3.40M6.72M16.00M26.22M
Current Assets 8.93M267.73M251.44M285.77M347.29M588.89M
Non-Current Assets
Property, Plant & Equipment (Net) 0.71M0.72M1.33M2.02M4.13M4.24M
Other Non-Current Assets 0.12M0.12M1.33M1.33M2.05M2.06M
Non-Current Assets 2.03M1.72M3.81M21.01M22.73M26.99M
Liabilities
Current Liabilities
Accounts Payables 2.09M2.15M3.65M3.34M5.45M4.60M
Payables 2.09M2.15M3.65M3.34M5.45M4.60M
Accumulated Expenses 2.02M4.61M7.34M12.75M17.92M20.87M
Current Leases 0.38M0.42M0.86M0.46M1.00M1.98M
Total Current Liabilities 4.49M7.18M11.85M16.55M24.37M27.45M
Non-Current Liabilities
Preferred Stock Liabilities 19.94M
Operating Leases 0.90M0.48M0.23M12.90M13.44M16.88M
Other Non-Current Liabilities 0.12M0.06M
Total Non-Current Liabilities 10.34M7.66M
Liabilities
Total Liabilities 10.46M7.72M12.08M29.36M37.81M44.33M
Shareholder's Equity
Common Equity -19.45M261.72M243.17M277.42M332.21M571.55M
Shareholder's Equity -19.45M261.72M243.17M277.42M332.21M571.55M
Liabilities and Shareholders Equity 10.96M269.44M255.25M306.78M370.02M615.89M
Retained Earnings -19.65M-65.01M-123.75M-228.43M-381.43M-568.78M
Treasury Shares 0.03M